172 filings
Page 4 of 9
ARS
xh468hx1
11 Aug 23
Annual report to shareholders
4:17pm
DEF 14A
qjqw7u4 6qk
11 Aug 23
Definitive proxy
4:15pm
8-K
s087 49ek4tvd
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
mqyoexswcs34o3k
10 Aug 23
Prospectus supplement
4:37pm
424B3
wi2srlso
10 Aug 23
Prospectus supplement
4:32pm
424B3
8mdmtnab 3mq8ot
10 Aug 23
Prospectus supplement
4:32pm
D
dejl48503g9mmfiks
7 Aug 23
$238.34 k in equity, sold $238.34 k, 1 investor
4:06pm
D
btcmssc7hve nnuxa
7 Aug 23
$4.07 mm in equity / options / securities to be acquired, sold $2.25 mm, 12 investors
4:03pm
PRE 14A
xq1yj 7uffbv
1 Aug 23
Preliminary proxy
5:08pm
8-K
f1ql 7pdnmwa006
1 Aug 23
Comera Life Sciences Announces $4.1 Million
4:08pm
424B3
hefr3 nb4j
19 May 23
Prospectus supplement
4:36pm
424B3
7kb3pxei
19 May 23
Prospectus supplement
4:32pm
8-K
90ckg9ue9kxqr
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
424B3
qkzdwu
19 May 23
Prospectus supplement
4:30pm
424B3
pnem8edb5jknlxsf3to
16 May 23
Prospectus supplement
4:33pm
424B3
rzafo5 t6oybnv74sev
16 May 23
Prospectus supplement
4:31pm
424B3
o70kefch4j2obz2psxn8
16 May 23
Prospectus supplement
4:31pm
424B3
5prnoejiey77ytcj0j
12 May 23
Prospectus supplement
4:42pm
424B3
s38lxu970fu5qm
12 May 23
Prospectus supplement
4:38pm